Thermo Fisher Scientific Inc
General ticker "TMO" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $200.8B
Thermo Fisher Scientific Inc follows the US Stock Market performance with the rate: 18.9%.
Estimated limits based on current volatility of 1.1%: low 515.03$, high 526.36$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-12-13, amount 0.39$ (Y0.30%)
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [514.33$, 724.03$]
- 2024-12-30 to 2025-12-30 estimated range: [579.75$, 803.28$]
Financial Metrics affecting the TMO estimates:
- Positive: Non-GAAP EPS, $ of 21.54 > 2.29
- Positive: 9.05 < Operating profit margin, % of 16.00
- Positive: Inventory ratio change, % of -1.02 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Negative: Investing cash flow per share, $ of -13.32 <= -3.48
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 5.69
Short-term TMO quotes
Long-term TMO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $39,211.00MM | $44,915.00MM | $42,857.00MM |
| Operating Expenses | $29,183.00MM | $36,522.00MM | $35,998.00MM |
| Operating Income | $10,028.00MM | $8,393.00MM | $6,859.00MM |
| Non-Operating Income | $-1,187.00MM | $-558.00MM | $-561.00MM |
| Interest Expense | $536.00MM | $726.00MM | $1,375.00MM |
| R&D Expense | $1,406.00MM | $1,471.00MM | $1,337.00MM |
| Income(Loss) | $8,841.00MM | $7,835.00MM | $6,298.00MM |
| Taxes | $1,109.00MM | $703.00MM | $284.00MM |
| Other Income(Loss) | $-4.00MM | $-172.00MM | $-59.00MM |
| Profit(Loss) | $7,728.00MM | $6,960.00MM | $5,955.00MM |
| Stockholders Equity | $40,793.00MM | $43,978.00MM | $46,735.00MM |
| Inventory | $5,051.00MM | $5,634.00MM | $5,088.00MM |
| Assets | $95,123.00MM | $97,154.00MM | $98,726.00MM |
| Operating Cash Flow | $9,543.00MM | $9,154.00MM | $8,406.00MM |
| Capital expenditure | $2,523.00MM | $2,243.00MM | $1,479.00MM |
| Investing Cash Flow | $-21,932.00MM | $-2,159.00MM | $-5,142.00MM |
| Financing Cash Flow | $6,581.00MM | $-2,810.00MM | $-3,622.00MM |
| Earnings Per Share* | $19.61 | $17.73 | $15.53 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.